My right honourable friend the Chancellor of the Exchequer (Jeremy Hunt) has today made the following Written Ministerial Statement.

On 26 May the government announced a package of measures totalling over £650m to drive growth and innovation in the Life Sciences sector.

The UK is rightly recognised as a world leader in...

My right honourable friend the Chancellor of the Exchequer (Jeremy Hunt) has today made the following Written Ministerial Statement.

On 26 May the government announced a package of measures totalling over £650m to drive growth and innovation in the Life Sciences sector.

The UK is rightly recognised as a world leader in...

Lords motion to take note of the Chancellor of the Exchequer’s Spring Budget 2023. (Part 1 of 2).

Lords motion to take note of the Chancellor of the Exchequer’s Spring Budget 2023. (Part 1 of 2).

Lords motion to take note of the Chancellor of the Exchequer’s Spring Budget 2023. (Part 2 of 2).

Lords motion to take note of the Chancellor of the Exchequer’s Spring Budget 2023. (Part 2 of 2).

My Lords, it is a privilege to open this debate on behalf of the Government and set out how we will move our economy on to a path of long-term sustainable growth. I start by welcoming my noble friend Lady Moyo to the House. I look forward to hearing her...

My Lords, it is a privilege to open this debate on behalf of the Government and set out how we will move our economy on to a path of long-term sustainable growth. I start by welcoming my noble friend Lady Moyo to the House. I look forward to hearing her...

My Lords, I thank all noble Lords for their contributions to this debate. Given the range of expertise that has been contributed today and the range of topics we have covered, I will spend my time directly answering as many of noble Lords’ comments as possible.

Many noble Lords reflected on...

My Lords, I thank all noble Lords for their contributions to this debate. Given the range of expertise that has been contributed today and the range of topics we have covered, I will spend my time directly answering as many of noble Lords’ comments as possible.

Many noble Lords reflected on...

The noble Lord may wish to know that the amendment is consequential on an amendment passed earlier on Report, so he or a fellow signatory may wish to move it.

Amendment 63

The noble Lord may wish to know that the amendment is consequential on an amendment passed earlier on Report, so he or a fellow signatory may wish to move it.

Amendment 63

My Lords, I know the noble Lord, Lord Hunt of Kings Heath has a long-term interest in and commitment to the work of NICE and, as such, will know that NICE’s remit is set out in other legislation. I do not intend to rehearse the arguments on why we do...

My Lords, I know the noble Lord, Lord Hunt of Kings Heath has a long-term interest in and commitment to the work of NICE and, as such, will know that NICE’s remit is set out in other legislation. I do not intend to rehearse the arguments on why we do...

My Lords, we now turn to the way in which reports are prepared and made on the exercise of the regulatory-making powers in the Bill.

Amendment 69 in the name of the noble Baroness, Lady Thornton, would make changes to the existing requirement to report, introduced in Grand Committee. It proposes...

My Lords, we now turn to the way in which reports are prepared and made on the exercise of the regulatory-making powers in the Bill.

Amendment 69 in the name of the noble Baroness, Lady Thornton, would make changes to the existing requirement to report, introduced in Grand Committee. It proposes...

Lords report stage second day. Amendment 17 agreed to. Amendment 18 agreed to on division (312 to 249). Amendments 19, 22, 23, 25, 26 (new clause), 27 to 33, 35 to 38, 39 (new clause), 40 to 45, 47, 49 to 50, 54 to 62, 63 (new clause), 64, 70 to 77, 79 to 91, 92 to 93 (new clauses), 94 to 97 agreed to. Bill, as amended, ordered to be printed (HL Bill 163).

Lords report stage second day. Amendment 17 agreed to. Amendment 18 agreed to on division (312 to 249). Amendments 19, 22, 23, 25, 26 (new clause), 27 to 33, 35 to 38, 39 (new clause), 40 to 45, 47, 49 to 50, 54 to 62, 63 (new clause), 64, 70...

The noble Baroness is correct that Amendment 27 is consequential to an amendment agreed on day 1 of Report, so she may wish to move it.

The noble Baroness is correct that Amendment 27 is consequential to an amendment agreed on day 1 of Report, so she may wish to move it.

My understanding is that Amendment 26 is also consequential to amendments passed on day 1 of Report, so we may wish to ask the

noble Lord, Lord Patel, whether he wishes to move his amendment, which is consequential to previous amendments agreed.

My understanding is that Amendment 26 is also consequential to amendments passed on day 1 of Report, so we may wish to ask the

noble Lord, Lord Patel, whether he wishes to move his amendment, which is consequential to previous amendments agreed.

My Lords, first, I would like to address the issue of patient and clinician access to affordable medicines in the UK. Patient and clinician access to affordable medicines is at the core of the NHS and this country’s healthcare policy. This Bill will not diminish that. Indeed, a safe and...

My Lords, first, I would like to address the issue of patient and clinician access to affordable medicines in the UK. Patient and clinician access to affordable medicines is at the core of the NHS and this country’s healthcare policy. This Bill will not diminish that. Indeed, a safe and...

Moved by

Baroness Penn

11: Clause 1, page 1, line 17, at end insert—

“(3A) Where regulations under subsection (1) may have an impact on the safety of human medicines, the appropriate authority may make the regulations only if the authority considers that the benefits of doing so outweigh the risks.”

Member’s explanatory statement

This...

Moved by

Baroness Penn

11: Clause 1, page 1, line 17, at end insert—

“(3A) Where regulations under subsection (1) may have an impact on the safety of human medicines, the appropriate authority may make the regulations only if the authority considers that the benefits of doing so outweigh the risks.”

Member’s explanatory statement

This...

My Lords, I begin by thanking all noble Lords for their valuable and ongoing engagement on the matters raised by Amendment 13. Throughout the Bill’s passage, we have heard numerous passionate and heartfelt speeches on the allegations of organ harvesting in China and how the UK seeks to guard against...

My Lords, I begin by thanking all noble Lords for their valuable and ongoing engagement on the matters raised by Amendment 13. Throughout the Bill’s passage, we have heard numerous passionate and heartfelt speeches on the allegations of organ harvesting in China and how the UK seeks to guard against...

My Lords, unfortunately the noble Lord cut out again briefly. If he could rewind about 30 seconds, that would be appreciated.

My Lords, unfortunately the noble Lord cut out again briefly. If he could rewind about 30 seconds, that would be appreciated.

My Lords, Amendment 15 in the name of the noble Lord, Lord Field of Birkenhead, deals with a topic that has been discussed at length in both Houses. The noble Lord spoke eloquently in Committee, sharing his experience of medicinal cannabis and the benefits he obtains from it.

I will first...

My Lords, Amendment 15 in the name of the noble Lord, Lord Field of Birkenhead, deals with a topic that has been discussed at length in both Houses. The noble Lord spoke eloquently in Committee, sharing his experience of medicinal cannabis and the benefits he obtains from it.

I will first...

Moved by

Baroness Penn

8: Clause 1, page 1, line 16, leave out “an attractive or” and insert “a”

Member’s explanatory statement

This amendment omits the word “attractive” from Clause 1(3)(c).

9: Clause 1, page 1, line 16, leave out “conduct clinical trials or supply human medicines” and insert “—

(i) carry out research relating to...

Moved by

Baroness Penn

8: Clause 1, page 1, line 16, leave out “an attractive or” and insert “a”

Member’s explanatory statement

This amendment omits the word “attractive” from Clause 1(3)(c).

9: Clause 1, page 1, line 16, leave out “conduct clinical trials or supply human medicines” and insert “—

(i) carry out research relating to...

Lords report stage first day. Government amendment 1, as new clause (The Commissioner for Patient Safety establishment and core duties etc), before clause 1, agreed to. Amendment 2 to clause 1 agreed to on division (324 votes to 241). Amendment 3 to clause 1 agreed to on division (320 votes to 236). Amendments 4 and 6 to clause 1 agreed to. Amendment 5 (to amendment 4) debated and withdrawn. Amendment 7 to clause 1 disagreed to on division (42 votes to 278). Government amendments 8 and 9 to clause 1 agreed to. Amendment 10 debated and withdrawn. Government amendment 11 agreed to. Amendment 13 to clause 2 agreed to. Amendment 14 to clause 3 debated and withdrawn. Amendment 15, as a new clause (Entitlement of a doctor to prescribe medicinal cannabis products), after clause 6, debated and withdrawn.

Lords report stage first day. Government amendment 1, as new clause (The Commissioner for Patient Safety establishment and core duties etc), before clause 1, agreed to. Amendment 2 to clause 1 agreed to on division (324 votes to 241). Amendment 3 to clause 1 agreed to on division (320 votes...

My Lords, when considering Amendment 7, tabled by the noble Baroness, Lady Bennett of Manor Castle, I draw the attention of noble Lords to our earlier discussion on the government amendments to this clause, introducing the requirement that safeguarding public health is the overarching objective when making regulations. The clause...

My Lords, when considering Amendment 7, tabled by the noble Baroness, Lady Bennett of Manor Castle, I draw the attention of noble Lords to our earlier discussion on the government amendments to this clause, introducing the requirement that safeguarding public health is the overarching objective when making regulations. The clause...

On the first point—considering environmental impacts in terms of research—obviously safety is one of the things primarily considered when looking at research on medicines. There is then separate provision in legislation for the safe disposal of any medicines that are not used. So we look at the safety of their...

On the first point—considering environmental impacts in terms of research—obviously safety is one of the things primarily considered when looking at research on medicines. There is then separate provision in legislation for the safe disposal of any medicines that are not used. So we look at the safety of their...